Menu Search
Equities

Kewaunee Scientific Corp

KEW:STU

Kewaunee Scientific Corp

Actions
  • Price (EUR)31.40
  • Today's Change0.20 / 0.64%
  • Shares traded0.00
  • 1 Year change+137.88%
  • Beta--
Data delayed at least 15 minutes, as of May 03 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture products. The Company operates through two segments: Domestic and International. The Domestic business segment principally designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, casework, flexible systems, worksurfaces, workstations, workbenches, and computer enclosures. The International business segment consists of foreign subsidiaries, such as Kewaunee Labway Asia Pte. Ltd., Kewaunee Scientific Corporation Singapore Pte. Ltd., Kewaunee Labway India Pvt. Ltd., Koncepo Scientech International Pvt. Ltd., and Kequip Global Lab Solutions Pvt. Ltd. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

  • Revenue in USD (TTM)201.04m
  • Net income in USD8.73m
  • Incorporated1970
  • Employees982.00
  • Location
    Kewaunee Scientific Corp2700 W Front StSTATESVILLE 28677United StatesUSA
  • Phone+1 (704) 873-7202
  • Fax+1 (302) 674-5266
  • Websitehttps://kewaunee.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.